NO902179D0 - Fremgangsmaate for fremstilling av stimulerende aminosyre-antagonister. - Google Patents

Fremgangsmaate for fremstilling av stimulerende aminosyre-antagonister.

Info

Publication number
NO902179D0
NO902179D0 NO902179A NO902179A NO902179D0 NO 902179 D0 NO902179 D0 NO 902179D0 NO 902179 A NO902179 A NO 902179A NO 902179 A NO902179 A NO 902179A NO 902179 D0 NO902179 D0 NO 902179D0
Authority
NO
Norway
Prior art keywords
amino acid
procedure
preparation
acid antagonists
stimulating amino
Prior art date
Application number
NO902179A
Other languages
English (en)
Other versions
NO177141B (no
NO902179L (no
NO177141C (no
Inventor
Boyd Lynn Harrison
Bruce Michael Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO902179D0 publication Critical patent/NO902179D0/no
Publication of NO902179L publication Critical patent/NO902179L/no
Publication of NO177141B publication Critical patent/NO177141B/no
Publication of NO177141C publication Critical patent/NO177141C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
NO902179A 1989-05-16 1990-05-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister NO177141C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (4)

Publication Number Publication Date
NO902179D0 true NO902179D0 (no) 1990-05-15
NO902179L NO902179L (no) 1990-11-19
NO177141B NO177141B (no) 1995-04-18
NO177141C NO177141C (no) 1995-07-26

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902179A NO177141C (no) 1989-05-16 1990-05-15 Analogifremgangsmåte for fremstilling av terapeutisk aktive aminosyreantagonister

Country Status (19)

Country Link
EP (1) EP0398283B1 (no)
JP (1) JP3014001B2 (no)
KR (1) KR0169107B1 (no)
CN (1) CN1027369C (no)
AT (1) ATE113597T1 (no)
AU (1) AU626418B2 (no)
DE (1) DE69013750T2 (no)
DK (1) DK0398283T3 (no)
ES (1) ES2066035T3 (no)
FI (1) FI95795C (no)
GR (1) GR3014893T3 (no)
HU (1) HU214322B (no)
IE (1) IE64671B1 (no)
IL (1) IL94377A (no)
NO (1) NO177141C (no)
NZ (1) NZ233641A (no)
PT (1) PT94042B (no)
TW (1) TW207950B (no)
ZA (1) ZA903588B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
KR100224045B1 (ko) * 1991-02-27 1999-10-15 슈테펜엘.네스비트 엔엠디에이(nmda) 길항제
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
MXPA02006474A (es) * 1999-12-28 2002-11-29 Eisai Co Ltd Compuestos heterociclicos que contienen sulfonamida.
RU2003129060A (ru) * 2001-03-14 2005-04-10 Грюненталь ГмбХ (DE) Замещенные пиразоло-и тиазолопиримидины
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
CA2721025C (en) 2008-04-11 2016-07-26 Merck Patent Gmbh Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
HUT54657A (en) 1991-03-28
AU5491490A (en) 1990-11-22
NO177141B (no) 1995-04-18
FI95795B (fi) 1995-12-15
IE64671B1 (en) 1995-08-23
IL94377A0 (en) 1991-03-10
PT94042A (pt) 1991-01-08
DK0398283T3 (da) 1994-11-28
PT94042B (pt) 1997-05-28
EP0398283B1 (en) 1994-11-02
NO902179L (no) 1990-11-19
JPH0311067A (ja) 1991-01-18
FI902416A0 (fi) 1990-05-15
NZ233641A (en) 1992-07-28
IE901750L (en) 1990-11-16
JP3014001B2 (ja) 2000-02-28
AU626418B2 (en) 1992-07-30
EP0398283A1 (en) 1990-11-22
DE69013750D1 (de) 1994-12-08
HU903031D0 (en) 1990-09-28
ATE113597T1 (de) 1994-11-15
FI95795C (fi) 1996-03-25
DE69013750T2 (de) 1995-05-24
KR0169107B1 (ko) 1999-01-15
ES2066035T3 (es) 1995-03-01
IL94377A (en) 1997-01-10
NO177141C (no) 1995-07-26
HU214322B (hu) 1998-03-02
TW207950B (no) 1993-06-21
GR3014893T3 (en) 1995-05-31
ZA903588B (en) 1991-02-27
CN1047292A (zh) 1990-11-28
CN1027369C (zh) 1995-01-11
KR900018112A (ko) 1990-12-20

Similar Documents

Publication Publication Date Title
NO902179L (no) Fremgangsmaate for fremstilling av stimulerende aminosyre-antagonister.
ATE126436T1 (de) Antagonisten von exzitatorischen aminosäuren.
DE69033308D1 (de) Decahydro-isochinolin-derivate
PT87754A (pt) Process for the preparation of new amino acid derivatives
DK46789D0 (da) 3-indolpyrodruesyrederivater og farmaceutisk anvendelse deraf
ATE106401T1 (de) Benzodiazepin-analoge.
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
DE69118539D1 (de) Exzitatorische Aminosäureantagonisten
ATE179169T1 (de) Prostaglandinanaloge
MX14957A (es) Nuevos derivados de tetrazol y procedimiento para su preparacion.
ES2054732T3 (es) Un procedimiento para preparar un derivado peptidico.
PL286043A1 (en) Method for manufacturing new proteins
BR9206404A (pt) Heteroaril-polimiaminas sintéticas como antagonistas de neurotransmissores aminoácidos excitadores
DE69230224D1 (de) Potenzierung von nmda-antagonisten
IT8819603A0 (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
FI883589A0 (fi) Menetelmä tyydyttämättömien aminohappoyhdisteiden valmistamiseksi
FI97388B (fi) Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
PT87528A (pt) Process for the preparation of vasopressin antagonists
NO180296C (no) Fremgangsmåte for fremstilling av cykliske aminosyre-forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2003